2 Results for "

RLS0071

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "RLS0071" in MCE Product Catalog:

Pegtarazimod
Pegtarazimod
0 Images
Referencia número: HY-P10868
No. CAS: 2056232-82-5
Synonyms: RLS-0071
Target:  

Reactive Oxygen Species (ROS)

Áreas de investigación:  

Infection Inflammation/Immunology

Pegtarazimod (RLS-0071) is a dual-target anti-inflammatory peptide that exerts its effects by simultaneously regulating the complement system and neutrophil-associated inflammatory pathways. Pegtarazimod reduces ROS production both in vitro and in vivo, and decreases the level of neutrophil elastase, a marker of neutrophil extracellular traps (NETs), in vivo, thereby alleviating inflammatory responses. Pegtarazimod significantly improves the survival rate of mice in multiple in vivo models of acute graft-versus-host disease (aGVHD). Pegtarazimod inhibits the activation of the C1 complex, reduces the herpes zoster-like spread of herpes simplex virus type 1 skin infection, and improves the survival rate of infected mice . Pegtarazimod can be used in research related to acute graft-versus-host disease, acute pulmonary diseases, and skin herpes simplex virus type 1 infection .
loading...
    loading...
View All Sizes
Pegtarazimod TFA
Pegtarazimod TFA
0 Images
Referencia número: HY-P10868A
Synonyms: RLS-0071 TFA
Target:  

Reactive Oxygen Species (ROS)

Áreas de investigación:  

Infection Inflammation/Immunology

Pegtarazimod TFA (RLS-0071 TFA) is a dual-target anti-inflammatory peptide that exerts its effects by simultaneously regulating the complement system and neutrophil-associated inflammatory pathways. Pegtarazimod TFA reduces ROS production both in vitro and in vivo, and decreases the level of neutrophil elastase, a marker of neutrophil extracellular traps (NETs), in vivo, thereby alleviating inflammatory responses. Pegtarazimod TFA significantly improves the survival rate of mice in multiple in vivo models of acute graft-versus-host disease (aGVHD). Pegtarazimod TFA inhibits the activation of the C1 complex, reduces the herpes zoster-like spread of herpes simplex virus type 1 skin infection, and improves the survival rate of infected mice . Pegtarazimod TFA can be used in research related to acute graft-versus-host disease, acute pulmonary diseases, and skin herpes simplex virus type 1 infection .
loading...
    loading...
View All Sizes
Assay Types